Share on LinkedInShare on LinkedIn

ARTICLE · 30 APRIL 2018

Delhi High Court Refuses To Interfere With CCI Prima Facie Order Post Investigation

One cannot restrict the scope of investigation, as it would defeat the very purpose of the Act which is to prevent practices having appreciable adverse effect on competition.

IndiaAntitrust/Competition Law

Article by MM Sharma, Head Competition Law & Policy Practice, Vaish Associates, Advocates, New Delhi, India

Delhi High Court   vide its recent judgement dated 09.03.2018 has refused to interfere in a pending inquiry after the submission of the Director General's (DG) investigation report .The High Court has provided clarity on the procedural issue which will enhance the powers of the Competition Commission of India (CCI), during the post-investigation inquiry under the Competition Act, 2002("the Act").

FACTS OF THE CASE

The petitioner , Cadilla Healthcare Limited , challenged the orders dated January 16, 2018 and January 17, 2018 and order dated November 17, 2015 passed CCI/ respondent No.1 ( hereinafter , the orders) , whereby , CCI dismissed an application for review / recall of its prima facie  order passed  under section 26(1) of the Act. It was submitted that the informant (Reliance Medical Agency) had placed an order for the supply of certain drugs/

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from